All Articles

Pantai Hospital KL's spot on Newsweek's 'World's Best' list highlights a national strategy built on superior quality, patient trust, and medical tourism.

As it turns six, crypto platform BYDFi expands into traditional finance, bolsters global regulatory compliance, and launches a $1M anniversary event.

Abbisko's irpagratinib gets EMA Orphan Drug status, fast-tracking a precision therapy for a hard-to-treat liver cancer subgroup with unmet needs.

Rinnai America promotes Perry McGuire, consolidating legal, lobbying, and HR as it battles regulations and champions 'consumer choice' in the appliance market.

Nodal Clear promotes Demetri Karousos to CEO and Huan Zhang to President, signaling a strategic focus on continuity, innovation, and risk management.

With a new SVP for APJ, Ivanti signals an aggressive strategy to conquer the region's complex IT and security market with its AI-powered platform.

A new survey reveals millions of homeowners will dig without calling 811, ignoring a simple step that prevents catastrophic utility strikes and costs.

China’s top infant formula maker is rewriting the global playbook, using cutting-edge research and local insight to challenge established giants in Southeast Asia.

A one-time gain gave the micro-cap a profitable quarter, but rising costs and reliance on a single large asset raise questions about its long-term stability.

A new ultra-low fee for large deals challenges traditional brokers and signals a digital revolution in the multi-billion dollar secondary market.

A new study reveals a significant financial confidence gap between military and civilian households, highlighting the impact of unique benefits and coaching.

Investors eye Alaska Air Group's Q1 results for insights on the Hawaiian Airlines integration, rising fuel costs, and shifting travel demand.

INLIF LIMITED's 1-for-16 reverse stock split aims to secure its Nasdaq listing, but is it a strategic fix or a sign of deeper financial trouble?

A landmark case could strip healthcare giants of a key legal defense, holding them accountable for allegedly deceiving seniors into for-profit Medicare plans.

Onfolio Holdings reports 36% revenue growth and positive EBITDA, but a wider net loss and auditor warnings reveal a high-stakes strategy for 2026.

The biopharma firm touts transformative drug data ahead, but with cash for only month-to-month operations, its future hangs by a precarious thread.

A landmark report from BC's counsellors' association pioneers a new era of transparency, linking operations to public trust and quality of care.

The energy services firm reports a 90% jump in adjusted EBITDA, crediting disciplined spending and a lucrative foray into the Alaskan snubbing market.

A scathing new report reveals systemic failures in federal Indigenous procurement, validating long-standing calls to end 'gilding' and phantom ventures.

The merger meant to launch a new-economy bank now includes a massive iron mine, raising questions about strategy, valuation, and management expertise.